Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: Are there specific patient characteristics or biomarkers to indicate response to treatment?

---

Kocaturk E., Baskan E. B., Engin B., Ozdemir M., Kucuk O. S., Can P., ...More

Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Lisbon, Portugal, 1 - 05 June 2019, vol.74, pp.484-485, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 74
• City: Lisbon
• Country: Portugal
• Page Numbers: pp.484-485
• Hacettepe University Affiliated: Yes